Related Experiment Video
Updated: Oct 28, 2025
07:36
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
Published on: July 3, 2025
308
Superimposed linear atopic dermatitis treated with dupilumab
Maria A Leszczynska1, Megan A Trainor1, Emily Henkel2
1Division of Dermatology and Dermatologic Surgery, Department of Internal Medicine, Dell Medical School at The University of Texas, Austin, TX, USA.
Pediatric Dermatology
|July 17, 2021
Summary
Severe linear atopic dermatitis, a rare skin condition, can occur due to mosaicism. This study reports the first successful treatment of this condition in a child using dupilumab.
Area of Science:
- Dermatology
- Genetics
Background:
- Atopic dermatitis is a common polygenic skin disorder.
- Rarely, it can manifest with a segmental or linear pattern due to cutaneous mosaicism.
- Only seven cases of superimposed linear atopic dermatitis have been documented previously.
Purpose of the Study:
- To present a case of severe superimposed linear atopic dermatitis in a child.
- To report the first successful use of dupilumab for treating this rare condition.
Main Methods:
- Clinical case presentation.
- Diagnostic evaluation for atopic dermatitis and mosaicism.
- Treatment with dupilumab.
Main Results:
- The child presented with severe superimposed linear atopic dermatitis.
- Dupilumab treatment led to successful clinical improvement.
- This marks the first reported instance of dupilumab efficacy in this specific condition.
Conclusions:
- Superimposed linear atopic dermatitis is a rare but treatable manifestation of cutaneous mosaicism.
- Dupilumab shows promise as an effective therapeutic option for severe cases.
- Further research is warranted to explore dupilumab's role in managing linear atopic dermatitis.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
848
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
848
01:19Antiasthma Drugs: Leukotriene Modifiers
849
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
849